20-F XBRL

FORM 20-F

Company: NYMOX PHARMACEUTICAL CORP
Filed: March 30, 2018
Period of Report: December 31, 2017
Accession Number: 0001640334-18-000561

View Document ↗ View on SEC.gov ↗